Metodesnitazene
| Metodesnitazene | |
|---|---|
| Salts [] | |
|---|---|
| Metodesnitazene hydrochloride | |
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 337.5 g/mol [1] |
| Predicted LogP | 4.1 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C21H27N3O [1] |
| IUPAC name | N,N-diethyl-2-[2-[(4-methoxyphenyl)methyl]benzimidazol-1-yl]ethanamine [1] |
| SMILES | CCN(CC)CCN1C2=CC=CC=C2N=C1CC3=CC=C(C=C3)OC [1] |
| InChI | InChI=1S/C21H27N3O/c1-4-23(5-2)14-15-24-20-9-7-6-8-19(20)22-21(24)16-17-10-12-18(25-3)13-11-17/h6-13H,4-5,14-16H2,1-3H3 [1] |
| InChIKey | SFNKTTXBZXVGOH-UHFFFAOYSA-N [1] |
Metodesnitazene (also known as N,n-diethyl-2-((4-methoxyphenyl)methyl)-1h-benzimidazole-1-ethanamine, 1H-benzimidazole-1-ethanamine, n,n-diethyl-2-((4-methoxyphenyl)methyl)-, N,N-diethyl-2-[(4-methoxyphenyl)methyl]-1H-benzimidazole-1-ethanamine, Dtxcid1083796, NSC659139, BENZIMIDAZOLE, 1-(2-(DIETHYLAMINO)ETHYL)-2-(p-METHOXYBENZYL)-, 1-(2-Diethylaminoethyl)-2-(p-methoxybenzyl)benzimidazole, Chebi:234370, Brn 0765000 or N,N-diethyl-2-[2-(4-methoxybenzyl)-1H-benzimidazol-1-yl]ethanamine) is a opioid substance of the nitazene class.
Chemistry
Salts []
Metodesnitazene is typically found in the form of its hydrochloride salt.
Stereochemistry []
Metodesnitazene is a achiral mixture.
Subjective effects []
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 26412, Metodesnitazene. Accessed June 7, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/26412
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Metodesnitazene. UNII: TTR2RT8GBY. Global Substance Registration System. Accessed June 7, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/TTR2RT8GBY